G1SK34 채권
아래는 GSK PLC DRN 회사채 목록입니다. 투자자들은 시장 변동성이 큰 시기에 안정성을 높이기 위해 회사채를 선택하는 경우가 많습니다. 가격, 수익률 및 기타 통계를 살펴보고 신뢰할 수 있는 투자처를 찾아보세요.
심볼 | YTM % | 거래량 | 가격 % | 쿠폰 % | 머튜어리티 데이트 | 미결제 금액 | 액면가 | 최소 액면 금액 | 발행자 |
|---|---|---|---|---|---|---|---|---|---|
| 117RIGLAXOSMITHKLINE CAPITAL PLC 4.25% GTD SNR EMTN 18/12/45 | 6.06% | 8.46 K | 82.51% | 4.25% | 2045-12-18 | 370.79 M GBP | 1,000.00 GBP | 100,000.00 GBP | GlaxoSmithKline Capital Plc |
| XXS217060907GLAXOSM.CAP. MTN 20/35MTN | 6.02% | 0 | 71.91% | 1.63% | 2035-05-12 | 750 M GBP | 1,000.00 GBP | 100,000.00 GBP | GlaxoSmithKline Capital Plc |
| GGSK3981911GlaxoSmithKline Capital, Inc. 4.2% 18-MAR-2043 | 5.68% | 90 K | 86.72% | 4.20% | 2043-03-18 | 500 M USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital, Inc. |
| 883GIGLAXOSMITHKLINE CAPITAL PLC 5.25% GTD SNR EMTN 10/04/2042 | 5.47% | 0 | 98.05% | 5.25% | 2042-04-10 | 477.82 M GBP | 1,000.00 GBP | 50,000.00 GBP | GlaxoSmithKline Capital Plc |
| 771ZCGLAXOSMITHKLINE CAPITAL PLC 6.375% GTD SNR EMTN 09/03/39 | 5.09% | 0 | 110.63% | 6.38% | 2039-03-09 | 631.3 M GBP | 1,000.00 GBP | 50,000.00 GBP | GlaxoSmithKline Capital Plc |
| GGSK.GJGlaxoSmithKline Capital, Inc. 6.375% 15-MAY-2038 | 5.06% | 3.32 M | 110.50% | 6.38% | 2038-05-15 | 2.75 B USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital, Inc. |
| UUS377373AH8GLAXOSM.CAP. 19/29 | 4.78% | 0 | 94.85% | 3.38% | 2029-06-01 | 1 B USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital Plc |
| AAG99GLAXOSMITHKLINE CAPITAL PLC 5.25% GTD SNR EMTN 19/12/2033 | 4.70% | 0 | 103.48% | 5.25% | 2033-12-19 | 574.17 M GBP | 1,000.00 GBP | 1,000.00 GBP | GlaxoSmithKline Capital Plc |
| XXS217060184GLAXOSM.CAP. MTN 20/28MTN | 4.70% | 0 | 88.84% | 1.25% | 2028-10-12 | 750 M GBP | 1,000.00 GBP | 100,000.00 GBP | GlaxoSmithKline Capital Plc |
| UUS377372AN7GLAXOSMITHKLINE CAP.18/28 | 4.62% | 0 | 97.80% | 3.88% | 2028-05-15 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital, Inc. |
| 772WIGLAXOSMITHKLINE CAPITAL INC 5.375% GTD SNR NTS 15/04/2034 | 4.57% | 0 | 105.28% | 5.38% | 2034-04-15 | 500 M USD | 1,000.00 USD | 1,000.00 USD | GlaxoSmithKline Capital, Inc. |
| GGSK4632357GlaxoSmithKline Capital, Inc. 3.625% 15-MAY-2025 | 4.34% | 2.1 M | 99.71% | 3.63% | 2025-05-15 | 1 B USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital, Inc. |
| XXS293369275GSK CAP B.V. 24/36 MTN | 3.22% | 0 | 100.29% | 3.25% | 2036-11-19 | 600 M EUR | 1,000.00 EUR | 100,000.00 EUR | GSK Capital BV |
| XXS255381776GSK CAP B.V. 22/32 MTN | 2.93% | 0 | 101.27% | 3.13% | 2032-11-28 | 700 M EUR | 1,000.00 EUR | 100,000.00 EUR | GSK Capital BV |
| GGX5CGLAXOSM.CAP. MTN 05/25 | 2.92% | 0 | 100.53% | 4.00% | 2025-06-16 | 750 M EUR | 1,000.00 EUR | 1,000.00 EUR | GlaxoSmithKline Capital Plc |
| XXS182282979GLAXOSM.CAP. MTN 18/30MTN | 2.90% | 0 | 94.61% | 1.75% | 2030-05-21 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | GlaxoSmithKline Capital Plc |
| XXS293369143GSK CAP B.V. 24/31 MTN | 2.86% | 0 | 100.09% | 2.88% | 2031-11-19 | 700 M EUR | 1,000.00 EUR | 100,000.00 EUR | GSK Capital BV |
| XXS168152035GLAXOSM.CAP. MTN 17/29 | 2.65% | 0 | 94.63% | 1.38% | 2029-09-12 | 500 M EUR | 1,000.00 EUR | 100,000.00 EUR | GlaxoSmithKline Capital Plc |
| XXS255381768GSK CAP B.V. 22/27 MTN | 2.60% | 0 | 101.09% | 3.00% | 2027-11-28 | 500 M EUR | 1,000.00 EUR | 100,000.00 EUR | GSK Capital BV |
| XXS182282812GLAXOSM.CAP. MTN 18/26MTN | 2.49% | 0 | 98.30% | 1.25% | 2026-05-21 | 1 B EUR | 1,000.00 EUR | 100,000.00 EUR | GlaxoSmithKline Capital Plc |
| GGX5BGLAXOSM.CAP. MTN 17/26 | 2.44% | 0 | 97.60% | 1.00% | 2026-09-12 | 700 M EUR | 1,000.00 EUR | 100,000.00 EUR | GlaxoSmithKline Capital Plc |
| 117RNGLAXOSMITHKLINE CAPITAL PLC 3.375% GTD SNR EMTN 20/12/2027 | 0.84% | 0 | 112.19% | 3.38% | 2027-12-20 | 307.77 M GBP | 1,000.00 GBP | 100,000.00 GBP | GlaxoSmithKline Capital Plc |
| AAQ72GLAXOSMITHKLINE CAPITAL PLC 0.883% GTD SNR EMTN 21/09/20 | — | — | — | 0.88% | 2028-09-21 | 42.5 B JPY | 100,000,000.00 JPY | — | GlaxoSmithKline Capital Plc |